Chemical Formula: C20H31O5-

Chemical Formula C20H31O5-

Found 31 metabolite its formula value is C20H31O5-

prostaglandin E2(1-)

prostaglandin E2(1-)

C20H31O5- (351.2171376)


The conjugate base of prostaglandin E2; major species at pH 7.3.

   

prostaglandin I2(1-)

prostaglandin I2(1-)

C20H31O5- (351.2171376)


D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Conjugate base of prostaglandin I2.

   

thromboxane A2(1-)

thromboxane A2(1-)

C20H31O5- (351.2171376)


Conjugate base of thromboxane A2 arising from deprotonation of the carboxylic acid function. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

prostaglandin D2(1-)

prostaglandin D2(1-)

C20H31O5- (351.2171376)


A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin D2., obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(5S,6E,8Z,10E,12E,14R,15S)-5,14,15-Trihydroxyicosa-6,8,10,12-tetraenoate

(5S,6E,8Z,10E,12E,14R,15S)-5,14,15-Trihydroxyicosa-6,8,10,12-tetraenoate

C20H31O5- (351.2171376)


D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

prostaglandin H2(1-)

prostaglandin H2(1-)

C20H31O5- (351.2171376)


Conjugate base of prostaglandin H2.

   

(5S,6R,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

(5S,6R,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C20H31O5- (351.2171376)


   

15-dehydro-prostaglandin E1(1-)

15-dehydro-prostaglandin E1(1-)

C20H31O5- (351.2171376)


Conjugate base of 15-dehydro-prostaglandin E1.

   

(5S,6Z,8E,10E,12R,14Z)-5,12,20-Trihydroxyicosa-6,8,10,14-tetraenoate

(5S,6Z,8E,10E,12R,14Z)-5,12,20-Trihydroxyicosa-6,8,10,14-tetraenoate

C20H31O5- (351.2171376)


   

13,14-dihydro-15-oxo-prostaglandin E2(1-)

13,14-dihydro-15-oxo-prostaglandin E2(1-)

C20H31O5- (351.2171376)


Conjugate base of 13,14-dihydro-15-oxo-prostaglandin E2.

   

(5S,15S)-5-hydroperoxy-15-HETE(1-)

(5S,15S)-5-hydroperoxy-15-HETE(1-)

C20H31O5- (351.2171376)


5-hydroperoxy-15-HETE(1-) that has 5S,15S configuration. The conjugate base of (5S,15S)-5-hydroperoxy-15-HETE. The major species at pH 7.3.

   

15-dehydroprostaglandin F2alpha

15-dehydroprostaglandin F2alpha

C20H31O5- (351.2171376)


   
   
   
   

(5S,7E,9E,11Z,13E,15S)-15-hydroperoxy-5-hydroxyicosa-7,9,11,13-tetraenoate

(5S,7E,9E,11Z,13E,15S)-15-hydroperoxy-5-hydroxyicosa-7,9,11,13-tetraenoate

C20H31O5- (351.2171376)


   

(5S,6E,8Z,11Z,13E,15R)-5-hydroperoxy-15-hydroxyicosa-6,8,11,13-tetraenoate

(5S,6E,8Z,11Z,13E,15R)-5-hydroperoxy-15-hydroxyicosa-6,8,11,13-tetraenoate

C20H31O5- (351.2171376)


   

20-hydroxy-6-trans-leukotriene B4(1-)

20-hydroxy-6-trans-leukotriene B4(1-)

C20H31O5- (351.2171376)


A leukotriene anion that is the conjugate base of 20-hydroxy-6-trans-leukotriene B4 arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

13,14-dihydro-15-oxolipoxin A4(1-)

13,14-dihydro-15-oxolipoxin A4(1-)

C20H31O5- (351.2171376)


A hydroxy fatty acid anion obtained by deprotonation of the carboxy function of 13,14-dihydro-15-oxolipoxin A4; major species at pH 7.3.

   

(12S)-hydroperoxy-(14R,15S)-epoxy-(5Z,8Z,10E)-icosatrienoate

(12S)-hydroperoxy-(14R,15S)-epoxy-(5Z,8Z,10E)-icosatrienoate

C20H31O5- (351.2171376)


A polyunsaturated fatty acid anion that is the conjugate base of (12S)-hydroperoxy-(14R,15S)-EET, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(12S)-hydroperoxy-(14S,15R)-epoxy-(5Z,8Z,10E)-icosatrienoate

(12S)-hydroperoxy-(14S,15R)-epoxy-(5Z,8Z,10E)-icosatrienoate

C20H31O5- (351.2171376)


A polyunsaturated fatty acid anion that is the conjugate base of (12S)-hydroperoxy-(14S,15R)-epoxy-(5Z,8Z,10E)-icosatrienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(5S)-hydroperoxy-(14R,15S)-epoxy-(6E,8Z,11Z)-icosatrienoate

(5S)-hydroperoxy-(14R,15S)-epoxy-(6E,8Z,11Z)-icosatrienoate

C20H31O5- (351.2171376)


A polyunsaturated fatty acid anion that is the conjugate base of (5S)-hydroperoxy-(14R,15S)-epoxy-(6E,8Z,11Z)-icosatrienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(8S)-hydroperoxy-(14S,15R)-epoxy-(5Z,9E,11Z)-icosatrienoate

(8S)-hydroperoxy-(14S,15R)-epoxy-(5Z,9E,11Z)-icosatrienoate

C20H31O5- (351.2171376)


A polyunsaturated fatty acid anion that is the conjugate base of (8S)-hydroperoxy-(14S,15R)-epoxy-(5Z,9E,11Z)-icosatrienoate, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

20-hydroxy prostaglandin A1

20-hydroxy prostaglandin A1

C20H31O5- (351.2171376)


   

(5S,6Z,8E,10E,12R,14Z)-5,12,19-trihydroxyicosa-6,8,10,14-tetraenoate

(5S,6Z,8E,10E,12R,14Z)-5,12,19-trihydroxyicosa-6,8,10,14-tetraenoate

C20H31O5- (351.2171376)


   

(5S,6Z,8E,10E,12R,14Z)-5,12,18-trihydroxyicosa-6,8,10,14-tetraenoate

(5S,6Z,8E,10E,12R,14Z)-5,12,18-trihydroxyicosa-6,8,10,14-tetraenoate

C20H31O5- (351.2171376)


   

(5S,6E,8Z,11Z,13E,15S)-15-hydroperoxy-5-hydroxyicosa-6,8,11,13-tetraenoate

(5S,6E,8Z,11Z,13E,15S)-15-hydroperoxy-5-hydroxyicosa-6,8,11,13-tetraenoate

C20H31O5- (351.2171376)


   

(S,S)-5,12-HpHETE(1-)

(S,S)-5,12-HpHETE(1-)

C20H31O5- (351.2171376)


   

5-hydroperoxy-15-HETE(1-)

5-hydroperoxy-15-HETE(1-)

C20H31O5- (351.2171376)


An icosanoid anion that is the conjugate base of 5-hydroperoxy-15-HETE, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   
   

(5Z,13E,15S,17Z)-9alpha,11alpha,15-Trihydroxyprosta-5,13,17-trien-1-Oate

(5Z,13E,15S,17Z)-9alpha,11alpha,15-Trihydroxyprosta-5,13,17-trien-1-Oate

C20H31O5- (351.2171376)